Skip to main content
NTHI
NASDAQ Life Sciences

NEONC Technologies Settles Legal Dispute for $737,920, Resolving Arbitration Case

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$9.63
Mkt Cap
$218.525M
52W Low
$3.2
52W High
$25
52W Position info
201% above low
Off High info
61% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

NTHI has more than doubled off its 52-week low of $3.2.

Summary

NEONC Technologies Holdings, Inc. announced the settlement of an ongoing legal dispute with Fox Infused, LLC, making a payment of $737,920.77, including interest.


Key Events · Legal and Risk Events · NTHI

  • Legal Dispute Settled

    NEONC Technologies Holdings, Inc. paid $737,920.77 to Fox Infused, LLC, including interest, to fully resolve a legal dispute stemming from a terminated intellectual property license and supply agreement.

  • Arbitration Case Concluded

    The payment concludes the arbitration case (Case No. 01-23-0002-5020) that Fox Infused had refiled after an initial court complaint was dismissed.


Analysis · NTHI · Life Sciences

This 8-K filing reports the resolution of a legal dispute that originated from a terminated intellectual property license and supply agreement. The company paid $737,920.77 to Fox Infused, LLC, which included $137,920.77 in interest on the original $600,000 settlement amount. While the payment represents a cash outflow, the settlement removes a contingent liability and the uncertainty associated with ongoing arbitration, which is a positive development for risk management.

How filings like this one have moved

In the 30 days to Sep 13, 2026, 29.5% of the 1672 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.22%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, NTHI was trading at $9.63 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $218.5M. The 52-week trading range was $3.20 to $25.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NTHI - Latest Insights

NTHI
Sep 10, 2026, 10:27 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.72
Real-time Price: $3.74 info
Change: +$0.025 (+0.67%) info
Market Cap: $95.446M info
NTHI
Sep 10, 2026, 10:25 AM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $3.73
Real-time Price: $3.74 info
Change: +$0.015 (+0.40%) info
Market Cap: $95.446M info
NTHI
Sep 09, 2026, 12:43 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $3.60
Real-time Price: $3.74 info
Change: +$0.140 (+4%) info
Market Cap: $95.446M info
NTHI
Aug 12, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $5.18
Real-time Price: $3.74 info
Change: -$1.44 (-28%) info
Market Cap: $95.446M info
NTHI
Aug 12, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $4.88
Real-time Price: $3.74 info
Change: -$1.14 (-23%) info
Market Cap: $95.446M info